Innovative Pharmaceutics SRL
Innovative Pharmaceutics reported total assets of €2.24m at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Jul 2026).
The score of Innovative Pharmaceutics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +11 % Total assets +9 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Innovative Pharmaceutics's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Jul 2026
- Year ended 31 Dec 2024filed on 14 Aug 2025
- Year ended 31 Dec 2023filed on 11 Jul 2024
- Year ended 31 Dec 2022filed on 13 Jul 2023
- Year ended 31 Dec 2021filed on 27 Aug 2022
Innovative Pharmaceutics's financial analysis
- Solvency99.4%sector median: 36.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Innovative Pharmaceutics
Innovative Pharmaceutics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0883.574.582
- VAT number
- BE0883574582
- Peppol
- Registered · 0208:0883574582 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Sep 2006
- Registered office
- 9052 Ghent
- Latest accounts
- 2025 · filed on 14 Jul 2026
- Activity
- Activities of agents involved in the wholesale of food, beverages and tobacco (NACE 46170)
Innovative Pharmaceutics (SRL) has been based in Ghent since 2006, active in: activities of agents involved in the wholesale of food, beverages and tobacco. For 2025, it reports a net profit of 77,375 € and equity of €2.22m; its revenue is not published. Its solvency stands at 99.4%, above the median of its sector (36.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Innovative Pharmaceutics
Companies in the same business, of comparable size and area, outside its group.
- Fedeco Foods Activities of agents involved in the wholesale of food, beverages and tobacco Lochristi · balance sheet €2.13m
- Capri.M Activities of agents involved in the wholesale of food, beverages and tobacco Nazareth-De Pinte · balance sheet €2.30m
- Sicil-Seedling Activities of agents involved in the wholesale of food, beverages and tobacco Merelbeke-Melle · balance sheet €1.04m
- Delimundo Activities of agents involved in the wholesale of food, beverages and tobacco Destelbergen · balance sheet €1.43m
- L.V.I. Activities of agents involved in the wholesale of food, beverages and tobacco Schelle · balance sheet €2.14m
- Kennedy Hotel Activities of agents involved in the wholesale of food, beverages and tobacco Brussels · balance sheet €2.07m
- Blue Mountain Activities of agents involved in the wholesale of food, beverages and tobacco Wevelgem · balance sheet €2.72m
- La Bécasse Activities of agents involved in the wholesale of food, beverages and tobacco Antwerp · balance sheet €2.84m
Frequently asked questions about Innovative Pharmaceutics
What is the revenue of Innovative Pharmaceutics?
Innovative Pharmaceutics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Innovative Pharmaceutics?
In Belgium, the VAT number is the company number prefixed with BE: BE0883574582 for Innovative Pharmaceutics, if the company is VAT-registered. Its company number (CBE) is 0883.574.582.
Where is the registered office of Innovative Pharmaceutics?
According to the CBE register, the registered office of Innovative Pharmaceutics is in 9052 Ghent.
What is the equity of Innovative Pharmaceutics?
At the close of the 2025 financial year, the equity of Innovative Pharmaceutics amounts to 2,224,271 €, a solvency of 99.4% of total assets.
Who manages Innovative Pharmaceutics?
The register lists 2 active mandates at Innovative Pharmaceutics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Innovative Pharmaceutics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →